James “Jay” Dixon has been appointed senior vice president of Quality and Compliance at Cetero Research. Mr. Dixon will lead the Quality and Compliance team, ensuring Cetero’s commitment to quality provides its clients with dependable and accurate results. Mr. Dixon has more than 25 years of experience in the pharmaceutical, biotechnology and CRO industries.

“We are thrilled to have someone of Jay’s caliber joining the Cetero team,” said chief executive officer Troy W. McCall, Ph.D. “Cetero considers quality and compliance to be the utmost priority. Jay’s qualifications and background will undoubtedly help raise Cetero’s benchmark for quality to an unprecedented new level.”

Most recently, Mr. Dixon led the quality and compliance efforts for MedImmune, as vice president of GxP Quality Compliance. Prior to that, he served as vice president of Global Quality Assurance and Business Process Improvement – Six Sigma, at Covance Central Laboratory Services. Mr. Dixon also held quality-focused leadership positions at Abbott Laboratories, Triangle Pharmaceuticals (now Gilead Sciences), PAREXEL International, ClinTrials Research and Glaxo Wellcome.